Lessons for the clinical nephrologist: lenalidomide-induced Fanconi syndrome in a patient with multiple myeloma post stem cell transplantation

J Nephrol. 2022 Nov;35(8):2139-2142. doi: 10.1007/s40620-022-01447-1. Epub 2022 Sep 11.
No abstract available

Keywords: Fanconi syndrome; Lenalidomide; Multiple myeloma; Stem cell transplantation.

MeSH terms

  • Bortezomib
  • Fanconi Syndrome* / chemically induced
  • Fanconi Syndrome* / diagnosis
  • Humans
  • Lenalidomide / adverse effects
  • Multiple Myeloma* / drug therapy
  • Nephrologists
  • Stem Cell Transplantation

Substances

  • Lenalidomide
  • Bortezomib